ArticleToxicology and applied pharmacology2019

Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors.

Catherine Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.